Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi-Gui Fu-Yuan is a Traditional Chinese Medicine (TCM) herbal formula primarily composed of *Astragalus membranaceus* (Huangqi) and *Angelica sinensis* (Danggui). It is designed to "tonify Qi" and "invigorate blood," and is commonly utilized in clinical settings in China for postoperative recovery, particularly following orthopedic surgeries such as hip or knee arthroplasty. The formula is hypothesized to alleviate postoperative fatigue syndrome (POFS) and prevent skeletal muscle atrophy by modulating inflammatory responses, reducing oxidative stress, and potentially regulating the TGF-β1/Smads and PI3K/Akt/mTOR signaling pathways. Clinical research, often conducted at institutions like the Gansu Provincial Hospital of TCM, has investigated its efficacy in improving physical function and reducing inflammatory markers like IL-6 and TNF-α in surgical patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qi-Gui Fu-Yuan.